Meiogenix
Meiogenix – Breeding technologies, genetic diversity, genome engineering.
Launch date
Employees
Market cap
-
Enterprise valuation
€47—71m (Dealroom.co estimates Dec 2021.)
Company register number 525187969
Paris Île-de-France (HQ)
Financials
Estimates*
EUR | 2015 | 2016 | 2017 |
---|---|---|---|
Revenues | <1m | <1m | <1m |
% growth | - | 16 % | 100 % |
EBITDA | (<1m) | (<1m) | (<1m) |
% EBITDA margin | (1020 %) | (1029 %) | (412 %) |
Profit | (<1m) | (<1m) | (<1m) |
% profit margin | (598 %) | (648 %) | (267 %) |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
* | €1.2m | Series A | |
N/A | Grant | ||
* | $13.0m | Series A | |
Total Funding | €13.0m |
Related Content
Recent News about Meiogenix
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.